We are live on ! Find out more
EVAR

Lombard Medical, Inc.
EVAR

Delisted

EVAR was delisted on the 8th of November, 2017.

14 hedge funds and large institutions have $9.64M invested in Lombard Medical, Inc. in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more funds holding

Funds holding: 914 (+5)

33% more capital invested

Capital invested by funds: $7.27M → $9.64M (+$2.37M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
14
Holders Change
+5
Holders Change %
+55.56%
% of All Funds
0.35%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
5
Increased
1
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

EVAR Hedge Fund Activity: Q1 2017 in Review

14 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Lombard Medical, Inc. (EVAR) for Q1 2017, worth a combined $9.64M — up 33% from $7.27M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new EVAR positions and 0 closed out — a net gain of 5 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $51.1K. The largest seller was UBS Group, cutting an estimated $10.9K.

  • 14 institutional investors held Lombard Medical, Inc. (EVAR) as of Q1 2017, up from 9 in Q4 2016.
  • Funds reported $9.64M of Lombard Medical, Inc. stock for Q1 2017, up 33% quarter-over-quarter.
  • 5 funds opened new Lombard Medical, Inc. positions in Q1 2017 and 0 closed out, a net change of +5 holders.
  • The largest Lombard Medical, Inc. buyer in Q1 2017 was Virtu KCG Holdings, an estimated $51.1K added.
  • The largest Lombard Medical, Inc. seller in Q1 2017 was UBS Group, an estimated $10.9K sold.

Based on aggregated 13F filings for Q1 2017.